Completed PHASE3 INTERVENTIONAL NCT00047723

Minocycline to Treat Amyotrophic Lateral Sclerosis

Sponsor: National Institute of Neurological Disorders and Stroke (NINDS)

Conditions Amyotrophic Lateral Sclerosis

Interventions minocycline

Updated 6 times since 2017 Last updated: Dec 18, 2007 Started: Jan 31, 2003 Completion: Jan 31, 2007

This information is for research purposes only and is not medical advice. Consult a healthcare provider before making any medical decision.

Listed as NCT00047723, this PHASE3 trial focuses on Amyotrophic Lateral Sclerosis and remains completed. Sponsored by National Institute of Neurological Disorders and Stroke (NINDS), it has been updated 6 times since 2003, reflecting limited change activity. This study adds to the evidence base for this therapeutic area through structured, versioned documentation.

Status Flow

Change History

6 versions recorded

Sep 2025 — Present [monthly]

Completed PHASE3
Sep 2024 — Sep 2025 [monthly]

Completed PHASE3
Jul 2024 — Sep 2024 [monthly]

Completed PHASE3
Jan 2021 — Jul 2024 [monthly]

Completed PHASE3
Jun 2018 — Jan 2021 [monthly]

Completed PHASE3

▶ Show 1 earlier version

Jan 2017 — Jun 2018 [monthly]

Completed PHASE3

First recorded

Jan 2003

Trial started

Per CT.gov start date — pre-dates our first snapshot

Eligibility Summary

No eligibility information available.

Contact Information

Sponsor contact:

National Institute of Neurological Disorders and Stroke (NINDS)

Data source: National Institute of Neurological Disorders and Stroke (NINDS)

For direct contact, visit the study record on ClinicalTrials.gov .

Study Locations

Albuquerque, United States , Burlington, United States , Charlotte, United States , Chicago, United States , Cleveland, United States , Dallas, United States , Denver, United States , Durham, United States , Houston, United States , Indianapolis, United States and 18 more locations